Y Mei, W Xiao, H Hu, G Lu, L Chen… - Clinical and …, 2021 - Wiley Online Library
Profiling heterologous cell types within tumors is essential to decipher tumor microenvironment that shapes tumor progress and determines the outcome of therapeutic …
Y Zhang, J Song, Z Zhao, M Yang, M Chen, C Liu, J Ji… - Cancer letters, 2020 - Elsevier
Colorectal cancer (CRC) is among the top 3 leading causes of cancer-related deaths, and tumor malignant progression and metastases contribute to the high mortality of advanced …
C Berlin, B Mauerer, P Cauchy… - The Journal of …, 2024 - Am Soc Clin Investig
Metastasized colorectal cancer (CRC) is associated with a poor prognosis and rapid disease progression. Besides hepatic metastasis, peritoneal carcinomatosis is the major …
W Wang, Y Zhong, Z Zhuang, J Xie, Y Lu… - Clinical and …, 2021 - Wiley Online Library
The tumor microenvironment is a complex ecosystem formed by distinct and interacting cell populations, and its composition is related to cancer prognosis and response to clinical …
Y Wu, S Yang, J Ma, Z Chen, G Song, D Rao, Y Cheng… - Cancer discovery, 2022 - AACR
Liver metastasis, the leading cause of colorectal cancer mortality, exhibits a highly heterogeneous and suppressive immune microenvironment. Here, we sequenced 97 …
R Wang, J Li, X Zhou, Y Mao, W Wang, S Gao… - Genome Medicine, 2022 - Springer
Background Colorectal cancer (CRC) ranks as the second-leading cause of cancer-related death worldwide with metastases being the main cause of cancer-related death. Here, we …
Background Distant metastasis accounts for 90% of deaths from colorectal cancer (CRC). Genomic heterogeneity has been reported in various solid malignancies, but remains …
Here, we developed and comprehensively characterized a cellular model of colon cancer progression consisting of four defined derivatives of a colon cancer cell line that resulted …
Y Wu, X Wang, F Wu, R Huang, F Xue, G Liang, M Tao… - 2012 - journals.plos.org
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in the world. A genome-wide screening of transcriptome dysregulation between cancer and normal tissue …